MiD expression is increased in PASMC from patients with PAH, and this upregulation of MiD49 and MiD51 increases fission and promotes a hyperproliferative, apoptosis-resistant, cancer-like PAH phenotype (Figure 8) [20]. The gene discussed is MIEF2; the disease is pulmonary arterial hypertension.